These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33270801)

  • 1. Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.
    Cheu RK; Gustin AT; Lee C; Schifanella L; Miller CJ; Ha A; Kim C; Rodriguez VJ; Fischl M; Burgener AD; Arnold KB; Alcaide ML; Klatt NR
    PLoS Pathog; 2020 Dec; 16(12):e1009024. PubMed ID: 33270801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.
    Velloza J; Heffron R
    Curr HIV/AIDS Rep; 2017 Oct; 14(5):153-160. PubMed ID: 28812207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiome and HIV prevention strategies in women.
    Abdool Karim SS; Passmore JS; Baxter C
    Curr Opin HIV AIDS; 2018 Jan; 13(1):81-87. PubMed ID: 29059077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
    Heffron R; McClelland RS; Balkus JE; Celum C; Cohen CR; Mugo N; Bukusi E; Donnell D; Lingappa J; Kiarie J; Fiedler T; Munch M; Fredricks DN; Baeten JM;
    Lancet HIV; 2017 Oct; 4(10):e449-e456. PubMed ID: 28732773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervicovaginal Microbiome Composition Is Associated with Metabolic Profiles in Healthy Pregnancy.
    Oliver A; LaMere B; Weihe C; Wandro S; Lindsay KL; Wadhwa PD; Mills DA; Pride DT; Fiehn O; Northen T; de Raad M; Li H; Martiny JBH; Lynch S; Whiteson K
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women.
    Mazibuko-Motau N; Sobia P; Xu J; Elsherbini JA; San JE; Lewis L; Mtshali A; Mzobe G; Ntuli L; Abdool Karim SS; Mansoor LE; Abdool Karim Q; Kwon DS; Archary D; Ngcapu S
    Sci Rep; 2022 Sep; 12(1):16187. PubMed ID: 36171447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
    Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
    Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
    PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors.
    Chehoud C; Stieh DJ; Bailey AG; Laughlin AL; Allen SA; McCotter KL; Sherrill-Mix SA; Hope TJ; Bushman FD
    AIDS; 2017 Apr; 31(7):895-904. PubMed ID: 28121709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.
    Farcasanu M; Kwon DS
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):30-38. PubMed ID: 29516267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
    Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME.
    Marrazzo JM
    Trans Am Clin Climatol Assoc; 2018; 129():63-73. PubMed ID: 30166700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.
    Wahl A; Ho PT; Denton PW; Garrett KL; Hudgens MG; Swartz G; O'Neill C; Veronese F; Kashuba AD; Garcia JV
    Sci Rep; 2017 Feb; 7():41098. PubMed ID: 28145472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Microbiome in Men Taking Pre-exposure Prophylaxis for HIV Prevention.
    Perler BK; Reinhart EM; Montgomery M; Maynard M; Shapiro JM; Belenky P; Chan PA
    AIDS Behav; 2021 Jul; 25(7):2005-2013. PubMed ID: 33394167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Resistance During HIV Pre-Exposure Prophylaxis.
    Gibas KM; van den Berg P; Powell VE; Krakower DS
    Drugs; 2019 Apr; 79(6):609-619. PubMed ID: 30963509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.
    Abdool Karim SS; Baxter C; Passmore JS; McKinnon LR; Williams BL
    J Int AIDS Soc; 2019 May; 22(5):e25300. PubMed ID: 31144462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
    Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
    J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.